The Ministerio de Ciencia e Innovación, within the State Plan for Scientific and Technical Research and Innovation 2013 2016 granted aid to the project "High Performance Cyanoacrylate Adhesives" led by CUANTUM COSMETICS S.L. with file number RTC-2016-5683-1. This project has been funded by the Ministry of Science and Innovation within the COLLABORATION CHALLENGES Subprogram, Call 2016. The project is co-financed by the European Union with the aim of promoting technological development, innovation and quality research.
Fondo Europeo de Desarrollo Regional (FEDER)
Una manera de hacer Europa
CUANTUM COSMETICS S.L participates in the project "LION-HD: Industrial research of strategic materials for high energy density and cost optimized lithium-ion batteries in sustainable electromobility" (MIG-20201021).
This project has been subsidized by the Center for Industrial Technological Development (CDTI) and is co-financed by the European Regional Development Fund (ERDF), in the call for 2019 of the MISSIONS Program, within the framework of the State Business Leadership Program in R + D + I, of the State Plan for Scientific and Technical Research and Innovation 2017-2020, with the support of the Ministry of Science and Innovation.
Woundfix BV, new commercial partner in consumer health channel
It is mainly indicated for:
• Closure of oral mucosa incision
• Surgical dressing
• Free gingival graft
• Closure of periodontal flaps
• Alveolar Osteitis
• Adjuvant to suture, reducing dehiscence and infection rate
A single layer of Cuantum Liquid Bandage, favourizes wound care for days.
Thanks to a new partnership, Cuantum Medical Cosmetics Eyelash Extension adhesives are available in USA and Canada.
Districa and Cuantum Medical, have agreed to commercialize Cuantum Oral Adhesive in Italian dental market.
Italian dentists have available oral liquid bandage indicated for wounds sealing and protection, free gingival grafts and surgical dressings.
Cuantum Medical Cosmetics, provides high performance adhesives for healthcare professionals.
Endovision has started commercialization of liquid bandages manufactured by CUANTUM Medical Cosmetics, in South-Korean animal health market.
Veterinary adhesive is available for professionals, which is indicated for skin wounds, dental procedures and minor surgeries in animals.
Thanks to this partnership, South Korean veterinary professionals have available advantages of liquid bandages during daily practice.
BETER and CUANTUM Medical Cosmetics, have signed a commercialization agreement, which allows to market MIMETIK® in Spain and Portugal healthcare market.
Manufactured product by Cuantum Medical Cosmetics is commercialized in pharmacies, parapharmacies and department stores available for domestic use.
MIMETIK® by BETER is a tissue adhesive, which protect from minor skin lesions: superficial cuts, chafing, scratches, cracks, erosions, stepparents and other skin lesions.
Cuantum Medical Cosmetics offers novedous and simply solutions for daily care.
Due to the continuous R&D team’s improvement, Cuantum introduces a new product within its veterinarian product range intended for pets and small animals.
Cura Rápido Plus+ is an extension of the already existing Cuantum Cura Rápido. This new product maintains the properties of the original one but presents a higher viscosity that allows an easier, simpler and more efficient application.
On this way, Cuantum Medical Cosmetics keeps working in order to achieve excellence within the tissue adhesive field.
With the launch of the Sport, Home and Professional lines, Cuantum positions itself as an alternative to regular bandages that can be found nowadays in the market, through the offer of an innovative product indicated for minor wound closures and skin lacerations that may occur while doing daily activities.
Composed of n-butyl cyanoacrylate, Cuantum + que una tirita creates a flexible and waterproof layer that sloughs off as the thermal layer regenerates. The flexibility of the resulting protector film allows realizing any task without causing any discomfort.
In this way, Cuantum increases prominently the company’s portfolio, which is going to develop both standard monomers and tailor-made monomers with purity levels above 99,0%.
The cyanoacrylate medical grade standard monomers catalogue will feature basically three different compounds: 2-octyl cyanoacrylate, n-Hexyl cyanoacrylate and n-butyl cyanoacrylate. Those molecules may be supplied on regular basis and in a quantity range from lab to industrial ones.
The monomers production process will be done according to the current good manufacturing practices (cGMP).
On the other side, tailor-made monomers will be manufactured according to the client needs and wants, varying the side chain structure according to what is needed. Cuantum will carry out the synthetic pathway development and the lab scale supply, with the possibility of scaling up the process.
The NEOTEC-CDTI programme has as its main objective the creation and consolidation of new companies with scientific-technological base. The program targets small and innovative companies (of maximum 4 years old) with a business plan that requires the use of technology or know-how developed from the research activity and whose business strategy is focused in technology development.
“+ que una tirita” represents a major development in front of regular bandages that can be found nowadays in the market as it works as a second artificial skin by creating a protector film. Composed of n-butyl cyanoacrylate it creates a slim resistant waterproof layer that naturally sloughs off as the affected dermic area regenerates. Its easy application makes it a perfect ally to fight against cracks, scrapes, blisters, small wounds and cuts among others. The release date for the feet care line is planned for this March, and will be found in 3 different distribution channels such as parapharmacy, shoe shops and shoe repair shops.
The thesis, titled “Controlled living anionic polymerization of cyanoacrylates by frustrated Lewis pair based initiator” studied the controlled polymerization of cyanoacrylate adhesives, achieved for the first time in this work. The results obtained offer promising business opportunities, as well as new applications for commercial products composed of cyanoacrylates.
As a result, the achievement of new long chain cyanoacrylates with superior features than the ones currently available has been foreseen, together with new formulations that allow to reduce significantly the healing time and provide material with improved stability in front of physiological environments, offering to the market broadly desired solutions. The proposed methodology considers the characterization of the toxicological and biocompatibility profile of the formulations, as well as its efficacy profile “ex vivo” and “in vivo” into a veterinary surgical environment. Finally, the optimization and escalation of manufacturing processes will be treated, assuring the commercial exploitation of the obtained results.
Barcelona January 28, 2016. Inveready has invested in Cuantum Medical Cosmetics, SA. Ramon Bacardit (previously executive at Henkel) and Ferran Pujol (former R&D manager at Spanish pharma Almirall) founded Cuantum in November 2015 to develop and market adhesives based on cyanoacrylates for medical, veterinary and cosmetic applications. Cuantum will commercialize cyanoacrylate monomers and formulations. The 1,6 million Euros round was raised from the founders, private investors, and Inveready.
”What attracted us to Cuantum, was the proven track-record of these serial entrepreneurs that have already shown an exceptional ability to generate high-growth businesses in mature markets in record time” says Sara Secall, Investment Director at Inveready.
These awards are made in recognition of scientific and technical merit to individuals and entities who have made significant contributio to the development of science and technology in Catalonia.
One recipient of this award is : Ramón Bacardit
Doctor of chemical research UAB. From 1981-2013 he worked in various positions in Henkel where he directed various R&D groups that generated more than 50 patents each year. From 2009-2013 he was an Honorary Professor in Tongii University, Shanghai. Today he is the CEO of Cuantum Medical and Cosmetics S.A. which is located in Campus UAB.
Cuantum Medical Cosmetics S.L., is located in the “Parc de Recerca de la Universitat Autònoma de Barcelona” (UAB), just in the “Edifici Eureka” in a high technological environment beside other activity related companies. This area is inside the UAB grounds, so very close to University Faculties and Research Centres, which facilitates the option of establishing high level contacts and working collaborations.
Our facilities are, a central office and a laboratory area, which is shared with Afinitica Technologies S.L., a company linked to Cuantum since its inception.
If you are interested in the Company, in any of its products or you’d like to request information about any item related to the Cyanoacrylate adhesives, please, do not hesitate to CONTACT us.